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Abstract
Introduction: The safety and efficacy of laparoscopic transperitoneal lateral adrenalec-
tomy and retroperitoneoscopic adrenalectomy have been reported. The aim is to report
the authors’ experience in laparoscopic left adrenalectomy with an alternative trans-
peritoneal submesocolic and retropancreatic approach with patient supine.
Researchmethods: The authors have performed laparoscopic transperitoneal submesocolic,
retropancreatic adrenalectomy for both benign and malignant, functioning lesions >4cm
in diameter or with smaller lesions but having an imaging pattern suspicious of malig-
nancy or of sub-clinically secreting tumors. After opening the posterior peritoneum at the
root of the transverse mesocolon and Gerota's fascia, the junction of the inferior adrenal
vein with the left renal vein is identified. The adrenal vein is then prepared and divided,
followed by mobilization and removal of the left adrenal gland.
Conclusion: Early ligation of the adrenal vein is the most relevant technical feature of
this procedure to avoid the release of catecholamines, hormones or neoplastic cells
which could occur during manipulation of the gland prior to ligation of the main
adrenal vein. Moreover, this approach makes it possible to perform associated proce-
dures, including a bilateral adrenalectomy, without the need to reposition the patient on
the operative table, but simply by positioning additional trocars.
Keywords: adrenal tumors, laparoscopic adrenalectomy, pheochromocytoma,
transperitoneal anterior approach, submesocolic retropancreatic approach
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1. Introduction
The surgical approach to the adrenal gland has raised debate among surgeons due to its
retroperitoneal location and for the complexity in the management of secreting tumors, partic-
ularly in case of pheochromocytoma (PHE) [1–3]. Traditionally, open adrenalectomy is made
difficult due to its deep anatomical location, and it is associated with up to 39% morbidity rate
and prolonged hospital stay [1–3]. In 1992, Gagner described the first laparoscopic adrenalec-
tomy (LA) by a transperitoneal approach with the patient in the lateral decubitus position [4,
5]. This initial experience has been followed by others using the same approach or, alterna-
tively, the retroperitoneal approach with the patient in the prone or in the lateral decubitus
position [6, 7] and the transperitoneal approach with the patient supine [8]. Several reports
have confirmed the safety and efficacy of these techniques, and minimally, invasive adrenalec-
tomy is presently considered the treatment of choice for a variety of benign lesions, including
lesions of the medulla [9, 10].
The aim of the present chapter is to report the authors’ experience with left laparoscopic
adrenalectomy (LA) using an original transperitoneal submesocolic and retropancreatic
approach with patient supine, to describe the patient's preparation for surgery as well as the
operative details of this procedure.
2. Methods
In order to establish the diagnosis in case of adrenal secreting lesions, all patients undergo
complete hormonal evaluation as previously reported [11]. Diurnal serum cortisol, dehydro-
epiandrosterone (DHEAS), plasma adrenocorticotropic hormone (ACTH), testosterone,
androstenedione, urinary free cortisol (UFC), 17-hydroxyprogesterone (17-OHP), renin
activity, aldosterone and urinary catecholamine levels are measured, together with over-
night 1-mg dexamethasone suppression test (DST) [11]. Aldosterone-producing adenoma,
pheochromocytoma and Cushing's syndrome are diagnosed on the basis of high plasma
aldosterone, plasma renin activity (PRA) ratio (>40) and unsuppressed aldosterone after
sodium load, elevated urinary metanephrines, elevated UFC, abnormal serum cortisol, inad-
equate cortisol suppression after 1-mg dexamethasone and low and/or suppressed plasma
ACTH [11]. When no specific signs and/or symptoms of autonomous hormone secretion are
present, or abnormal hypothalamus-pituitary-adrenal axis tests and radiological imaging
suggesting the presence of an adrenocortical lesion, a diagnosis of nonfunctioning adenoma
is made [11].
All patients are studied with computed tomography (CT) scan and magnetic resonance imag-
ing (MRI). An attenuation value of 1O or less Hounsfield units (HU) on unenhanced CT scan is
suggestive for the presence of a benign adrenocortical adenoma [12]. Relative contrast washout
of >40% and an absolute contrast washout of >60% are suggestive for an adenoma, with 92%
specificity and 98% sensitivity rates, respectively [13, 14]. In all sequences during MRI,
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adrenocortical adenomas are homogeneous, with mild gadolinium enhancement [12], with
low or equal signal intensity as the liver on T2-weighted images may appear on lower signal
intensity than the rest of the adrenal gland [12]. Chemical shift imaging can be done during
MRI to identify fat within the lesion as decreased signal intensity relative to normal tissue [12].
For carcinomas, the attenuation on unenhanced studies is higher than 10HU on CT scan [15].
On contrast-enhanced studies, carcinomas enhance greedily due to their vascularity, and the
enhancement pattern may be homogeneous, unless there is central necrosis [15, 16]. The
relative percentage washout of carcinomas is <40% [17]. At MRI, adrenal carcinomas are noted
for heterogeneity on T1-weighted images, with intermediate to high signal intensity [18].
Heterogeneity is also noted on T2-weighted images due to hemorrhage and/or necrosis [18].
Based on these criteria, adrenal lesions larger than 4cm in diameter or with smaller but having
an imaging pattern suspicious of malignancy or of sub-clinically secreting tumors are an
indication for laparoscopic adrenalectomy.
2.1. Patient's preoperative preparation
2.1.1. Pheochromocytoma
Alpha-blockers (doxazosin 20mg/day), starting at least 15days before surgery, are adminis-
tered. If patients reported episodes of tachycardia, beta-blockers are also administered (ateno-
lol 100–200mg/day orally). On the day before surgery, treatment with alpha-blockers is
discontinued, and intravenous (iv) normal saline 2000cc is administered to expand the plasma
volume [19].
2.1.2. Conn's syndrome
Iv hydrocortisone 100mg is administered at induction of anesthesia. Iv spironolactone is used
for potassium control [20].
2.1.3. Cushing's syndrome
Iv hydrocortisone 100mg is administered at induction of anesthesia and then iv hydrocorti-
sone 50mg every 8h [20].
2.2. Surgical technique
2.2.1. Left adrenalectomy: transperitoneal anterior submesocolic and retropancreatic approach
Surgery is performed under general anesthesia. An orogastric tube and urinary catheter are
positioned. Intraoperative patients’monitoring includes intra-arterial radial artery catheter for
continuous blood pressure measurement and a central venous catheter (subclavian or internal
jugular access) for rapid infusion of liquids. Pneumoperitoneum is usually established with a
Veress needle at the umbilicus or with an open technique and Hasson cannula, in case of the
presence of abdominal scars from previous surgery. Pneumoperitoneum is set at a pressure of
12–13mmHg, with carbon dioxide flow adjusted at 30lt/min. Four trocars and a 30°/45°
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forward oblique optic are used. This approach is performed with the patient supine, in slight
anti-Trendelenburg position and with the operating table turned 30° with the side opposite the
lesion down, to facilitate exposure of the surgical field. The surgeon stands on the side which is
ipsilateral to the lesion.
After induction of pneumoperitoneum, the first 12-mm optical trocar (n. 1) is inserted on the
left of the midline above the umbilicus (Figure 1). A second 12-mm trocar (n. 2) is inserted
under vision on the right midclavicular line below the right costal arch. The third and fourth
12-mm trocars are placed one on the left midclavicular line along with the transverse umbilical
line (n. 3) and other on the left anterior axillary line (n. 4), respectively (Figure 1). The 10-mm
laparoscope is introduced from trocar (n. 3), while trocars 1 and 4 are the operating ones. With
atraumatic forceps introduced from trocar (n. 2), the transverse mesocolon is raised by the
assistant. This maneuver discloses the first jejunal loop at the ligament of Treitz, and it shows
the arch of the inferior mesenteric vein. The operative table is tilted with the left side of the
patient up, which allows the surgeon to displace the first jejunal loops on the patient's right
side (Figure 2). The posterior peritoneum is opened at the insertion of the transverse
mesocolon and posteriorly to the lower edge of the pancreas, between the first jejunal loop
and the arch of the inferior mesenteric vein or immediately lateral to this vessel, according to
Figure 1. Trocars’ position during left transperitoneal submesocolic and retropancreatic adrenalectomy. The surgeon and
first assistant stand on the left of the patient, while the second assistant stands on the right.
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its distance from the jejunum. Toldt's fascia appears at this point as a whitish film. The
dissection then proceeds posteriorly along the retro-pancreatic space, after raising the body of
the pancreas with an atraumatic instrument held by the surgeon's left hand. The splenic vein is
visible at this point running along the posterior aspect of the pancreas. Gerota's fascia is now
opened to visualize the left renal vein, which is followed medially, until the left inferior adrenal
vein is identified. This is cautiously prepared and divided between clips (AcuClip, Tyco/
Healtcare, Norwalk, Connecticut, USA, Figure 3). No manipulation of the left adrenal gland
has yet occurred prior to division of the adrenal vein because the gland is located cranially to
this vessel. Only at this point, the gland is mobilized using a radiofrequency (LigaSure™ tissue
fusion, Covidien, Mansfield, Massachusetts, USA) or ultrasonic (Ultracision, Harmonic Scal-
pel, Ethicon Endo Surgery, Cincinnati, Ohio, USA) device, and the specimen is removed from
the abdominal cavity inside a specimen retrieval bag after slightly enlarging the periumbilical
trocar incision [19].
Near-infrared indocyanine green (NIR-ICG) fluorescence may be employed during surgery
and may be useful to aid in vascular structures and adrenal gland identification amidst
retroperitoneal and perirenal fat, particularly in obese patients, to improve the safety of
laparoscopic adrenalectomy.
Figure 2. After raising the transverse mesocolon and displacing the first jejunal loop on the patient's right side, the
posterior peritoneum is divided close to the arch of the inferior mesenteric vein.
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3. Discussion
Surgery is the standard treatment of Conn's syndrome, Cushing's disease, pheochromocy-
toma, primary adrenal cancer and adrenal metastases. After the introduction of minimally
invasive adrenalectomy, this has now become the treatment of choice [8, 21–26]. Minimally,
invasive adrenalectomy is mostly performed either with a transperitoneal lateral approach or
with a retroperitoneal approach [4]. The laparoscopic transperitoneal anterior approach has
been proposed only by few centers [8, 11, 19, 23, 24, 26].
The transperitoneal lateral approach, originally described by Gagner et al. [4], is performed
with the patient in the lateral decubitus position. It gives excellent exposure of the operative
field with a wide working space, and it facilitates orientation by providing readily identifiable
anatomical landmarks [27]. Its proponents report several advantages, such as a rapid and
direct access to the gland without the need to retract any organ and with minimal patient
trauma [28], a clear operative field due to gravity that keeps blood and bowel away from it and
the need for less surgical dissection on the left side, as compared to the anterior approach [26].
By the authors’ opinion, the main disadvantage of the lateral approach is that it does not
provide early ligation of the adrenal vein prior to gland manipulation, which the authors
Figure 3. The left adrenal vein is divided between clips. Confluence of the diaphragmatic vein to the left adrenal vein is
visible.
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believe to be important so as to avoid pressure instability in case of secreting adenomas, and
particularly of pheochromocytoma, and which would also be oncologically correct [11, 19, 29].
Retroperitoneal adrenalectomy (RA) has also been reported to be safe and effective [21, 30, 31].
According to its proponents, it is preferred to reduce the risks and possible complications of a
transperitoneal access, such as incisional hernias and paralytic ileus from bowel manipulation
[4, 7]. It has been reported to require less analgesics due to lower postoperative pain [27] and to
be associated with earlier recovery of bowel function, possibly leading to shorter hospital stay
[27]. However, minimal postoperative pain, early liquid diet and a short hospital stay have
been reported also after a laparoscopic approach [5, 6, 26, 27]. RA is preferred in patients with
abdominal adhesions from previous surgery and in obese patients [32]. Moreover, several
authors reported a shorter operative time [28]. According to Walz et al. [33], a 7cm hormonally
active tumor or a 4–7cm nonfunctioning tumor may be indications for a retroperitoneal
approach. By the opinion of these authors, severe obesity, simultaneous abdominal pathology,
patients with evident signs of malignancy or a tumor exceeding 8cm are contraindications for
the retroperitoneal approach [33]. In our opinion, the patient's position during RA is unfavor-
able for rapid conversion to open surgery in case of major bleeding and may itself impair or
worsen the hemodynamic conditions of the patient [8].
Moreover, both lateral LA and RA do not allow to perform associated surgical procedures [11,
19, 34]. In lateral LA, exploration of the contralateral gland is not possible without
repositioning the patient [11, 19, 34], which increases the operative time.
To reduce the risk of catecholamines, hormones or neoplastic cells spread from the adrenal
gland, the authors introduced the laparoscopic transperitoneal submesocolic and retro-
pancreatic approach with the patient supine. This approach was originally described by Pierre
Delbet in 1912 [35]. Its main advantages are the limited extent of the dissection and early
identification, ligation and division of the left adrenal vein which is obtained prior to any
gland manipulation. This aspect is particularly important in case of secreting lesions. In fact,
the authors consider early clipping of the main adrenal vein to be of upmost importance,
together with avoiding any manipulation of the gland prior to adrenal vein ligation [11, 19,
24, 26, 36].
With respect to the transperitoneal anterior and lateral approaches, it does not require mobili-
zation of the left colonic flexure or of the spleno-pancreatic complex to gain access to the
adrenal gland, with reduction of the operative time and of potential operative risks. However,
it does require experience in advanced laparoscopic surgery because the operation is
conducted in a restricted working space adjacent to major venous vessels, such as the left renal
and splenic veins, and the aorta [11, 19, 37].
In case of LA or RA for pheochromocytoma, because of the complexity of the disease, the
operation should be performed only in centers with a well established, multidisciplinary
experience in the diagnosis and treatment of adrenal gland pathology. In fact, surgery for
pheochromocytoma is at risk of hypotensive or hypertensive crisis, or both, due to an excess
in catecholamine release, which cannot be completely prevented even by adequate preopera-
tive preparation with α-blockers [10]. The aim of medical treatment prior to surgery is not the
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reduction of hormonal secretion but the prevention of the peripheral effects of catecholamines
secreted by the tumor, so that the patient may undergo surgery under the best cardiovascular
conditions [38]. Advances in intraoperative monitoring and the introduction of preoperative α1-
receptors’ blockade have radically reduced the mortality rate [39]. A significant increase in the
rates of plasma norepinephrine release related to mobilization of the adrenal gland has been
reported during LAwith a lateral approach [39]. One study also reported that severe hyperten-
sion was triggered by direct manipulation of the adrenal gland [10]. Instead, no significant
intraoperative change in blood pressure was observed following this surgical strategy in case of
pheochromocytoma [19]. Based on the authors’data, the anterior laparoscopic submesocolic and
retropancreatic approach for treatment of secreting adrenal lesions is safe [11, 19, 24].
Authors N Approach
Mean age
(years)
Mean oper.
time (min.)
Conversion
(%)
Morbidity
(%)
H.S.
(days)
Hazzan [2] 24 Lateral 45.4 188 7 16 4
Vargas [3] 20 Lateral 47 193 10 10 3.1
Gagner [5] 100 Lateral 46 130 3 12 2.5
Bonjer [6] 79 RP 50 114 6.3 10.1 2
Salomon [7] 21 RP 46 116 0 19 3.4
Lang [9] 56 RP 36.2 52 1.8 1.7 5.2
Janetschek [10] 19 Lateral 49.7 150 0 16 7
Mohammadi-Fallah [27] 11 Lateral 43 129 0 9.1 3.6
12 RP 42 128 8.3 8.3 3.1
Dickson [30] 23 Lateral 42 145 4.3 8.7 3.1
23 RP 47 100 13 13 1.9
Fernández-Cruz [31] 16 Lateral 36 89 12.5 12.5 3
14 RP 47 105 14.2 0 2.75
Walz [33] 560 RP 49.2 67 1.7 11.8 –
Cabalag [44] 13 Lateral 47 105 0 30.7 2
10 RP 61 90 0 10 1
Paganini [11] 19 LASA 54 92 0 0 4.4
Paganini [19] 37 LASA 54 82.7 0 0 3.85
Matsuda [29] 75 Anterior – 221 0 3.9 10.2
Linos [45] 18 Anterior 48.7 116 5.5 0 2.3
N, number of patients; H.S, hospital stay; RP, retroperitoneal; LASA, left anterior submesocolic approach.
Table 1. Patient series reported in the literature.
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Some authors [40, 41] consider tumors larger than 6cm to be a contraindication for a minimally
invasive approach, due to the risk of malignancy. In the authors’ experience, the size of the
largest lesion up to 10cm in diameter did not affect the feasibility and the outcome of the
procedure or the operative time [11, 19, 24]. This observation has been confirmed by Parnaby
et al. [42], whose results are in agreement with the authors’ experience [11, 19, 24].
Moreover, the supine position of the patient allows one to perform associated diagnostic [43]
or operative procedures, such as contralateral adrenalectomy, without the need to reposition
the patient on the operative table. In the authors’ experience, the submesocolic approach was
associated with a significant reduction in the operative time, as compared to the laparoscopic
traditional anterior approach, which compares favorably also with the operative time of the
lateral and retroperitoneal approaches reported in the literature (Table 1) [2, 3, 5–7, 9–11, 19,
27, 29–31, 33, 44, 45].
Independently from the approach that is followed, the recent introduction of a dedicated
laparoscopic instrumentation to detect near-infrared fluorescence with indocyanine green
(NIR-ICG) improves visualization of the inferior adrenal vein and of the adrenal gland with
respect to the surrounding fat, making their identification easier [46, 47]. In the authors’
opinion, this instrumentation might improve the safety of the procedure, as well as the onco-
logical outcome in case of adrenal cancer or metastases.
LAwith transperitoneal submesocolic and retropancreatic approach has proven to be safe and
effective [11, 19, 24], and its results are in line with those reported in the most recent literature
[48] after RA and lateral LA. Early ligation of the adrenal vein is the most important technical
feature of this technique in every type of lesion. For more objective results, a multicenter
randomized clinical trial comparing the submesocolic approach with lateral LA and RA for
left adrenalectomy would be required.
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